Age-specific bone turnover prevalence in women with post-menopausal osteoporosis: possibilities of traditional plant therapy during COVID-19 pandemic

Pandemic
DOI: 10.30574/wjarr.2022.16.3.1391 Publication Date: 2022-12-26T10:15:21Z
ABSTRACT
Post-menopausal osteoporosis is a chronic age-related illness marked by decrease of bone density and quality, as well higher risk fragility fractures. Fragility fractures are recognized to have major impact on individuals society both personal financially. In recent years, it has been hidden epidemic impacting over 200 million people globally. It claimed that one fracture happens every three seconds throughout the world. The termination ovarian hormone production, which causes rapid loss, puts postmenopausal women at greater developing osteoporosis. gradual changes in structure, quality bones lead rise morbidity death among menopausal women. Interventions enhance woman’s well-being life reducing intensity frequency post-menopausal Hormone therapy helpful managing symptoms; nevertheless, linked number potentially significant side effects, including development breast cancer. As result, there an increase demand for alternative treatment options. Plant species with potential antiosteoporosis characteristics highlighted further discussed order aid future medication treating this illness. Many plants components demonstrated action based vast chemical pharmacological studies. Plant-derived molecules lately piqued curiosity researchers working novel medicinal agents. therapeutic interventions can delay reduce or prevent loss ageing people, especially women, essential person’s life. included review those frequently used traditional medicine shown clinical efficacy management While numerous treat osteoporosis, only fraction discussed, their origin, active components, activity, we evaluated challenges methods utilized during COVID-19 pandemic.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)